clinical studies on ceftriaxone ( ro 13-9904 , ctrx ) were carried out and the results were as follows : twelve patients ( acute purulent tonsillitis 1 , pneumonia 6 , urinary tract infection 5 ) were treated with ctrx , in doses of 21-48 mg/kg divided 2 times per day for 3.5-8 days intravenously .
C0007561
ceftriaxone
C0042029
urinary tract infection